DA4-JC
DA4-JC has been studied in 1 paper since 2021: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Jan 1, 2021: “A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease”.
1 paper studies it5 findingsUpdated
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Animals1
What did studies of DA4-JC find?
5Studies of DA4-JC measured 5 outcomes, among them mitophagy, amyloid and Synapses.
Mitophagy
upin mice1
1 study
Mitophagy
upin mice1
DA4-JC activates mitophagy in mice (PINK1-Parkin signaling).
“improving the phosphatase and tensin homologue induced putative kinase 1 (PINK1) - Parkin mitophagy signaling pathway”
AnimalsPINK1-Parkin signaling
Journal of Alzheimer's disease : JAD
Amyloid
downin mice1
1 study
Amyloid
downin mice1
DA4-JC decreases amyloid in APP/PS1/tau mice.
“downregulating amyloid, p-tau, and autophagy marker P62 levels”
Animalsin APP/PS1/tau mice
Journal of Alzheimer's disease : JAD
Synapses
upin mice1
1 study
Synapses
upin mice1
DA4-JC increases synapses in APP/PS1/tau mice.
“increased numbers of synapses and dendritic spines”
Animalsin APP/PS1/tau micehippocampus
Journal of Alzheimer's disease : JAD
long-term potentiation
upin mice1
1 study
long-term potentiation
upin mice1
DA4-JC increases long-term potentiation in APP/PS1/tau mice.
“enhanced LTP in the hippocampus”
Animalsin APP/PS1/tau micehippocampus
Journal of Alzheimer's disease : JAD
Cognitive impairment
downin mice1
1 study
Cognitive impairment
downin mice1
DA4-JC decreases cognitive impairment in APP/PS1/tau mice.
“DA4-JC improved cognitive impairment in a range of tests”
Animalsin APP/PS1/tau mice
Journal of Alzheimer's disease : JAD